샘플 요청 목록

 카트 문의
시장보고서
상품코드
1507233

암 통증 관리 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 통증 유형별, 약물 유형별, 암 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)

Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 암 통증 관리 시장 규모는 2032년까지 83억 9,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

암 통증 관리 시장은 빠르게 성장하고 있습니다. 암 통증은 경증부터 중증까지 다양하며, 날카로운 찌르는 듯한 통증, 따끔거리는 통증, 타는 듯한 통증, 지속적인 통증 등 다양한 형태로 나타납니다. 암 통증은 삶의 질에 미치는 영향이 크고, 암의 증상과 치료의 부작용을 악화시킵니다. 또한 우울증과 불안장애를 일으킬 가능성도 높아집니다. 따라서 적절한 통증 관리는 암 치료에 있어 매우 중요합니다.

또한, 암 치료 관리 서비스는 환자의 암 여정 전반에 걸쳐 통증 관리를 포함한 증상 관리를 최적화하는 데 중점을 두고 있습니다. 환자 개개인의 고유한 필요와 선호도에 맞춰 전인적이고 배려심 있는 치료를 제공합니다. 효과적인 암성 통증 관리를 위해서는 암 전문의, 통증 전문의, 암 치료팀, 간호사, 사회복지사 및 기타 의료 전문가들이 협력하여 암 환자의 복잡하고 개별화된 요구를 충족시켜야 합니다.

최근 만성 통증 완화에 효과적인 방법으로 침술이 추가되었습니다. 이 중국 전통 의학 치료법은 피부의 특정 부위에 미세한 침을 꽂아 조작하는 것입니다. 과학적 연구를 통해 특정 통증에 대한 침술의 효과가 입증되었지만, 암 관련 통증 관리에 대한 침술의 효과에 대한 증거는 제한적입니다. 경피적 전기신경자극(TENS) 치료는 피부에 부착된 전극을 통해 낮은 수준의 전류를 흐르게 하여 신체의 반응을 유도하여 통증을 완화합니다.

암 통증 관리 시장 보고서 하이라이트

중등도에서 중증의 통증을 완화하는 특성을 가진 오피오이드 약물이 시장을 독점하고 있습니다.

비오피오이드 약물 부문은 주로 경증에서 중등도 통증 관리에 효과적이기 때문에 예측 기간 동안 CAGR로 성장할 것으로 예상됩니다.

폐암 분야는 폐암 유병률의 증가와 폐암 관련 통증의 빈도가 높아지면서 폐암 분야가 가장 큰 시장 점유율을 차지하고 있습니다.

병원 부문은 병원 환경에 대한 환자들의 선호도와 신뢰가 높아지면서 시장을 크게 가속화했습니다.

북미가 시장을 독식한 이유는 암 유병률 증가와 헬스케어 서비스에 대한 수요 증가로 인해 북미가 시장을 주도하고 있기 때문입니다.

목차

제1장 소개

제2장 주요 요약

제3장 조사 방법

제4장 세계의 암 통증 관리 시장 인사이트

  • 암 통증 관리 - 업계 현황
  • 암 통증 관리 시장 역학
    • 성장 촉진요인과 기회
      • 고령화 인구 증가
      • 암 통증 관리의 기술의 진보
    • 성장 억제요인과 과제
      • 고액의 치료비
  • PESTLE 분석
  • 암 통증 관리 업계 동향
  • COVID-19의 영향 분석

제5장 세계의 암 통증 관리 시장 : 통증 유형별

  • 주요 조사 결과
  • 소개
  • 급성 통증
  • 만성 통증

제6장 세계의 암 통증 관리 시장 : 약물 유형별

  • 주요 조사 결과
  • 소개
  • 오피오이드
  • 비오피오이드
  • 코르티코스테로이드
  • 항우울제
  • 항불안제
  • 항경련제
  • 신경 차단제

제7장 세계의 암 통증 관리 시장 : 암 유형별

  • 주요 조사 결과
  • 소개
  • 폐암
  • 대장암
  • 유방암
  • 전립선암
  • 혈액암
  • 기타

제8장 세계의 암 통증 관리 시장 : 용도별

  • 주요 조사 결과
  • 소개
  • 면역요법
  • 화학요법
  • 방사선 치료
  • 홈 테라피
  • 기타

제9장 세계의 암 통증 관리 시장 : 최종 용도별

  • 주요 조사 결과
  • 소개
  • 병원
  • 암 치료 클리닉
  • 기타

제10장 세계의 암 통증 관리 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 암 통증 관리 시장 평가 : 지역별, 2019-2032년
  • 북미
    • 북미 : 통증 유형별, 2019-2032년
    • 북미 : 용도별, 2019-2032년
    • 북미 : 의약품 유형별, 2019-2032년
    • 북미 : 암 유형별, 2019-2032년
    • 북미 : 최종 용도별, 2019-2032년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 통증 유형별, 2019-2032년
    • 유럽 : 용도별, 2019-2032년
    • 유럽 : 의약품 유형별, 2019-2032년
    • 유럽 : 암 유형별, 2019-2032년
    • 유럽 : 최종 용도별, 2019-2032년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
  • 아시아태평양
    • 아시아태평양 : 통증 유형별, 2019-2032년
    • 아시아태평양 : 용도별, 2019-2032년
    • 아시아태평양 : 의약품 유형별, 2019-2032년
    • 아시아태평양 : 암 유형별, 2019-2032년
    • 아시아태평양 : 최종 용도별, 2019-2032년
    • 중국
    • 인도
    • 일본
    • 말레이시아
    • 인도네시아
    • 한국
  • 중동 및 아프리카
    • 중동 및 아프리카 : 통증 유형별, 2019-2032년
    • 중동 및 아프리카 : 용도별, 2019-2032년
    • 중동 및 아프리카 : 의약품 유형별, 2019-2032년
    • 중동 및 아프리카 : 암 유형별, 2019-2032년
    • 중동 및 아프리카 : 최종 용도별, 2019-2032년
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
  • 라틴아메리카
    • 라틴아메리카 : 통증 유형별, 2019-2032년
    • 라틴아메리카 : 용도별, 2019-2032년
    • 라틴아메리카 : 의약품 유형별, 2019-2032년
    • 라틴아메리카 : 암 유형별, 2019-2032년
    • 라틴아메리카 : 최종 용도별, 2019-2032년
    • 멕시코
    • 브라질
    • 아르헨티나

제11장 경쟁 상황

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제12장 기업 개요

  • BioDelivery Sciences
  • Daiichi Sankyo
  • Eli Lilly & Company
  • Endo Pharmaceuticals
  • Johnson & Johnson Inc
  • Mallinckrodt Pharmaceuticals
  • Pfizer Inc
  • Prostrakan Group
  • Sanofi S.A.
  • Teva Pharmaceuticals
ksm 24.07.11

The global cancer pain management market size is expected to reach USD 8.39 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer pain management market is witnessing rapid growth. Cancer pain can range from mild to severe and present in various forms, such as sharp stabbing pain, tingling, burning sensation, or a persistent ache. The impact of cancer pain on your quality of life is significant, worsening cancer symptoms and treatment side effects. Additionally, it can heighten the likelihood of developing depression and anxiety. Therefore, proper pain management is crucial in cancer treatment.

Additionally, cancer care management services focus on optimizing symptom management, including pain control, throughout the cancer journey of the patient. They provide holistic and compassionate care tailored to each patient's unique needs and preferences. Effective cancer pain management requires a collaborative effort from oncologists, pain specialists, cancer care teams, nurses, social workers, and other healthcare professionals to address the complex and individualized needs of cancer patients.

In recent years, additional methods that could be beneficial in alleviating chronic pain include acupuncture. This traditional Chinese medicine practice entails the insertion and manipulation of thin needles into specific areas of the skin. While scientific research has demonstrated the effectiveness of acupuncture in treating certain types of pain, there is limited evidence regarding its efficacy in managing cancer-related pain. Transcutaneous electrical nerve stimulation (TENS) therapy involves the application of a low-level electrical current through electrodes placed on the skin, eliciting a response from the body that helps alleviate pain.

Cancer Pain Management Market Report Highlights

The opioids segment dominated the market, largely attributable to their property to alleviate moderate to severe pain.

The non-opioids drug segment is projected to grow at a CAGR during the projected period, mainly driven by its effectiveness in managing mild to moderate pain.

The lung cancer segment accounted for the largest market share, attributed to the rising prevalence of lung cancer, a higher frequency of pain related to lung cancer.

The hospitals segment dominated the market highly accelerated due to the increasing preference and trust of patients towards hospital settings.

The North America region dominated the market attributed to the increasing prevalence of cancer has created a greater demand for healthcare services.

The global key market players include BioDelivery Sciences, Daiichi Sankyo, Eli Lilly & Company, Endo Pharmaceuticals, Johnson & Johnson Inc., etc.

Polaris Market Research has segmented the cancer pain management market report based on pain type, drug type, cancer type, application, end-use, and region:

Cancer Pain Management, Pain Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Acute Pain
  • Chronic Pain

Cancer Pain Management, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Opioid
  • Morphine
  • Fentanyl
  • Others
  • Non-opioids
  • Non-steroidal anti-inflammatory drug
  • Acetaminophen
  • Corticosteroids
  • Anti-depressants
  • Anti-anxiety drugs
  • Anti-convulsant drugs
  • Nerve Blockers

Cancer Pain Management, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Lung Cancer
  • Colorectal cancer
  • Breast cancer
  • Prostate cancer
  • Blood cancer
  • Others

Cancer Pain Management, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Immunotherapy
  • Chemotherapy
  • Radiotherapy
  • Home Therapy
  • Others

Cancer Pain Management, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Cancer Care Clinics
  • Others

Cancer Pain Management, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Pain Management Market Insights

  • 4.1. Cancer Pain Management - Industry Snapshot
  • 4.2. Cancer Pain Management Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Geriatric Population
      • 4.2.1.2. Rising Technology in Cancer Pain Management
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Cancer Pain Management Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Cancer Pain Management Market, by Pain Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • 5.3. Acute Pain
    • 5.3.1. Global Cancer Pain Management Market, by Acute Pain, by Region, 2019-2032 (USD Billion)
  • 5.4. Chronic Pain
    • 5.4.1. Global Cancer Pain Management Market, by Chronic Pain, by Region, 2019-2032 (USD Billion)

6. Global Cancer Pain Management Market, by Drug Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • 6.3. Opioid
    • 6.3.1. Global Cancer Pain Management Market, by Opioid, by Region, 2019-2032 (USD Billion)
    • 6.3.2. Morphine
      • 6.3.2.1. Global Cancer Pain Management Market, by Morphine, by Region, 2019-2032 (USD Billion)
    • 6.3.3. Fentanyl
      • 6.3.3.1. Global Cancer Pain Management Market, by Fentanyl, by Region, 2019-2032 (USD Billion)
    • 6.3.4. Others
      • 6.3.4.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)
  • 6.4. Non-opioids
    • 6.4.1. Global Cancer Pain Management Market, by Non-opioids, by Region, 2019-2032 (USD Billion)
    • 6.4.2. Non-steroidal anti-inflammatory drug
      • 6.4.2.1. Global Cancer Pain Management Market, by Non-steroidal anti-inflammatory drug, by Region, 2019-2032 (USD Billion)
    • 6.4.3. Acetaminophen
      • 6.4.3.1. Global Cancer Pain Management Market, by Acetaminophen, by Region, 2019-2032 (USD Billion)
  • 6.5. Corticosteroids
    • 6.5.1. Global Cancer Pain Management Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 6.6. Anti-depressants
    • 6.6.1. Global Cancer Pain Management Market, by Anti-depressants, by Region, 2019-2032 (USD Billion)
  • 6.7. Anti-anxiety drugs
    • 6.7.1. Global Cancer Pain Management Market, by Anti-anxiety drugs, by Region, 2019-2032 (USD Billion)
  • 6.8. Anti-convulsant drugs
    • 6.8.1. Global Cancer Pain Management Market, by Anti-convulsant drugs, by Region, 2019-2032 (USD Billion)
  • 6.9. Nerve Blockers
    • 6.9.1. Global Cancer Pain Management Market, by Nerve Blockers, by Region, 2019-2032 (USD Billion)

7. Global Cancer Pain Management Market, by Cancer Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • 7.3. Lung Cancer
    • 7.3.1. Global Cancer Pain Management Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 7.4. Colorectal cancer
    • 7.4.1. Global Cancer Pain Management Market, by Colorectal cancer, by Region, 2019-2032 (USD Billion)
  • 7.5. Breast cancer
    • 7.5.1. Global Cancer Pain Management Market, by Breast cancer, by Region, 2019-2032 (USD Billion)
  • 7.6. Prostate cancer
    • 7.6.1. Global Cancer Pain Management Market, by Prostate cancer, by Region, 2019-2032 (USD Billion)
  • 7.7. Blood cancer
    • 7.7.1. Global Cancer Pain Management Market, by Blood cancer, by Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Cancer Pain Management Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • 8.3. Immunotherapy
    • 8.3.1. Global Cancer Pain Management Market, by Immunotherapy, by Region, 2019-2032 (USD Billion)
  • 8.4. Chemotherapy
    • 8.4.1. Global Cancer Pain Management Market, by Chemotherapy, by Region, 2019-2032 (USD Billion)
  • 8.5. Radiotherapy
    • 8.5.1. Global Cancer Pain Management Market, by Radiotherapy, by Region, 2019-2032 (USD Billion)
  • 8.6. Home Therapy
    • 8.6.1. Global Cancer Pain Management Market, by Home Therapy, by Region, 2019-2032 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Cancer Pain Management Market, by End-Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 9.3. Hospitals
    • 9.3.1. Global Cancer Pain Management Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 9.4. Cancer Care Clinics
    • 9.4.1. Global Cancer Pain Management Market, by Cancer Care Clinics, by Region, 2019-2032 (USD Billion)
  • 9.5. Others
    • 9.5.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

10. Global Cancer Pain Management Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Cancer Pain Management Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Cancer Pain Management Market - North America
    • 10.3.1. North America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.3.3. North America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.3.4. North America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.3.5. North America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.3.6. Cancer Pain Management Market - U.S.
      • 10.3.6.1. U.S.: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.3.7. Cancer Pain Management Market - Canada
      • 10.3.7.1. Canada: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.4. Cancer Pain Management Market - Europe
    • 10.4.1. Europe: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.6. Cancer Pain Management Market - UK
      • 10.4.6.1. UK: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.7. Cancer Pain Management Market - France
      • 10.4.7.1. France: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.8. Cancer Pain Management Market - Germany
      • 10.4.8.1. Germany: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.9. Cancer Pain Management Market - Italy
      • 10.4.9.1. Italy: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.10. Cancer Pain Management Market - Spain
      • 10.4.10.1. Spain: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.11. Cancer Pain Management Market - Netherlands
      • 10.4.11.1. Netherlands: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.12. Cancer Pain Management Market - Russia
      • 10.4.12.1. Russia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.5. Cancer Pain Management Market - Asia Pacific
    • 10.5.1. Asia Pacific: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.6. Cancer Pain Management Market - China
      • 10.5.6.1. China: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.7. Cancer Pain Management Market - India
      • 10.5.7.1. India: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.8. Cancer Pain Management Market - Japan
      • 10.5.8.1. Japan: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.9. Cancer Pain Management Market - Malaysia
      • 10.5.9.1. Malaysia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.10. Cancer Pain Management Market - Indonesia
      • 10.5.10.1. Indonesia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.11. Cancer Pain Management Market - South Korea
      • 10.5.11.1. South Korea: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.6. Cancer Pain Management Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.6. Cancer Pain Management Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.7. Cancer Pain Management Market - UAE
      • 10.6.7.1. UAE: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.8. Cancer Pain Management Market - Israel
      • 10.6.8.1. Israel: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.9. Cancer Pain Management Market - South Africa
      • 10.6.9.1. South Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.7. Cancer Pain Management Market - Latin America
    • 10.7.1. Latin America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.6. Cancer Pain Management Market - Mexico
      • 10.7.6.1. Mexico: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.7. Cancer Pain Management Market - Brazil
      • 10.7.7.1. Brazil: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.8. Cancer Pain Management Market - Argentina
      • 10.7.8.1. Argentina: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. BioDelivery Sciences
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Daiichi Sankyo
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly & Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Endo Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Johnson & Johnson Inc
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Mallinckrodt Pharmaceuticals
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Pfizer Inc
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Prostrakan Group
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Sanofi S.A.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Teva Pharmaceuticals
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제